Nevro Corp. (NVRO) Financial Analysis & Valuation | Quarter Chart
Nevro Corp. (NVRO)
NVROPrice: $5.84
Fair Value: 🔒
🔒score
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, ... more
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in... more
Description
Shares
| Market Cap | $224.09M | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Kevin R. Thornal |
| IPO Date | 2014-11-06 | CAGR | 0.3% |
| Employees | 1,099 | Website | www.nevro.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | -0.3% | Total Yield | -0.3% |
NVRO chart loading...
Fundamentals
Technicals
| Enterprise Value | $296.56M | P/E Ratio | -1.91 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 0.73 | P/B Ratio | 0.95 |
| P/CF Ratio | 16.7 | P/FCF Ratio | 36 |
| EPS | $-3.06 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | -3.92% | Gross Margin | 0.65% |
| Operating Margin | -0.29% | Profit Margin | -0.29% |
| ROE | -0.34% | ROA | -0.16% |
| ROCE | -0.2% | Current Ratio | 4.62 |
| Quick Ratio | 3.62 | Cash Ratio | 0.92 |
| Debt/Equity | 1.09 | Interest Coverage | -4.44 |
| Altman Z Score | -0.6 | Piotroski Score | 2 |